The pharmaceutical and biotech sectors, which had been left behind in the semiconductor-driven market, have recently shown strong performance. The healthcare index has significantly outperformed the semiconductor index, attracting substantial foreign buying. Eased U.S. tariff risks and news of global new drug and technology transfers are boosting domestic investor sentiment.


Securities firms predict that this trend will continue through the first half of next year. Global trends such as obesity and metabolic disease treatments, along with domestic companies' technology exports and new drug approval achievements, are having a positive impact, leading to the analysis that there is ample room for further gains. Experts advise, "It is effective to devise a bio investment strategy alongside semiconductor and high-dividend stocks to match the rotational market expected through the end of the year."

Are Pharmaceuticals and Biotech Emerging as New Market Leaders? How to Maximize the Opportunity View original image

[Link to the No.1 industry leader HisStockLoan: https://www.hisl.co.kr/5113]


Meanwhile, interest in stock-backed loans (stock loans) continues to rise. Investors who do not want to miss out on rare investment opportunities are turning to stock loans, which allow them to utilize more funds for stock purchases.


Additionally, even if investors using margin or credit experience a sharp drop in stock prices and face a forced sale crisis, one of the advantages of stock loans is that they can easily switch without providing additional collateral or selling holdings, and simply wait for a rebound.


◆ HisStockLoan: Additional investment funds at the industry's lowest annual interest rate in the 4% range, plus refinancing of margin and credit loans!

HisStockLoan has launched a securities-linked credit product that anyone can use comfortably, offering the industry's lowest annual interest rate in the 4% range. It can be used for both stock purchases and refinancing of securities firm margin/credit loans, and up to four times the investor's own capital can be utilized regardless of credit rating.


In addition, for investors who previously had difficulty using stock loans due to DSR (Debt Service Ratio) limits, a product is now available that can be used regardless of DSR. Investors using the alternative trading system (NXT) can also take advantage of these services.


Investors who want to learn more about the various customized products offered by HisStockLoan can contact the customer service center (☎1566-5113) at any time, 24 hours a day, for convenient consultation with a professional advisor, regardless of loan eligibility.


○ Launch of products with the industry's lowest annual interest rate in the 4% range

○ Products available regardless of DSR

○ No.1 market share for 21 consecutive years, winner of the Korea First Brand Award for 16 consecutive years

○ Real-time repayment of securities firm margin/credit loans

○ Trading available on the alternative trading system (NXT)

○ Reliable consultation quality guarantee system

* HisStockLoan Customer Service Center: 1566-5113

Go to: https://www.hisl.co.kr/5113


Green Optics, The Pinkfong Company, U2Bio, Jaeyoung Solutec, Mirae Nanotech



※ The above content is unrelated to the editorial direction of The Asia Business Daily, and all responsibility lies with the information provider.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing